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Abstract
Background:  Although currently available evidence predominantly recommends early laparoscopic
cholecystectomy (LC) for the treatment of acute cholecystitis, this strategy has not been widely adopted
in Japan. Herein, we describe a hospital-based study of patients with acute cholecystitis in 9 Japanese
teaching hospitals in order to evaluate the impact of different institutional strategies in treating acute
cholecystitis on overall patient outcomes and medical resource utilization.
Methods: From an administrative database and chart review, we identified 228 patients diagnosed with
acute cholecystitis who underwent cholecystectomy between April 2001 and June 2003. In order to
examine the relationship between hospitals' propensity to perform LC and patient outcomes and/or
medical resource utilization, we divided the hospitals into three groups according to the observed to
expected ratio of performing LC (LC propensity), and compared the postoperative complication rate,
length of hospitalization (LOS), and medical charges.
Results: No hospital adopted the policy of early surgery, and the mean overall LOS among the subjects
was 30.9 days. The use of laparoscopic surgery varied widely across the hospitals; the adjusted rates of LC
to total cholecystectomies ranged from 9.5% to 77%. Although intra-operative complication rate was
significantly higher among patients whom LC was initially attempted when compared to those whom OC
was initially attempted (9.7% vs. 0%), there was no significant association between LC propensity and
postoperative complication rates. Although the postoperative time to oral intake and postoperative LOS
was significantly shorter in hospitals with high use of LC, the overall LOS did not differ among hospital
groups with different LC propensities. Medical charges were not associated with LC propensity.
Conclusion: Under the prevailing policy of delayed surgery, in terms of the postoperative complication
rate and medical resource utilization, our study did not show the superiority of LC in treating acute
cholecystitis patients. The timing of surgery and discharge was mainly determined by the institutional policy
in Japan, rather than by the clinical course of the patient; however, considering the substantially less
postoperative pain and shorter recovery time of LC compared to OC, LC should be actively applied for
the treatment of acute cholecystitis. If the policy of early surgery were universally applied, the advantage
of LC over OC may be more clearly demonstrated.
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Background
The treatment strategy for acute cholecystitis is now a
topic of hot debate. The two main controversies regarding
the treatment of acute cholecystitis in patients fit for sur-
gery are the timing of cholecystectomy (either initial con-
servative treatment followed by delayed cholecystectomy
or planned early cholecystectomy), and the selection of
the surgical procedure for cholecystectomy (either laparo-
scopic surgery or laparotomy). The currently available evi-
dence predominantly supports immediate
cholecystectomy on the basis that early surgery does not
increase the risk of operative morbidity and mortality
associated with early cholecystectomy, [1-6] and that such
a measure reduces the hospital stay for each patient by up
to ten days, in contrast to conservative (late) cholecystec-
tomy. [7,8] Nevertheless, this strategy has not been widely
adopted in Japan or in other countries. [9,10]
Another controversy is the selection of laparoscopic sur-
gery in cholecystectomy. Since its introduction, laparo-
scopic cholecystectomy (LC) has quickly become the most
widely used treatment for gallstone disease, because of
substantially less postoperative pain and a shorter recov-
ery time compared to open cholecystectomy (OC); [11]
however, the indications and contraindications for LC
vary widely between providers.[9,10,12-15] In early
reports, acute cholecystitis was considered to be an abso-
lute contraindication to this approach. In contrast, subse-
quent reports showed excellent outcomes for laparoscopic
management of acute cholecystitis, and advocated the use
of this modality for this population. [16,17] Two rand-
omized clinical trials compared OC and LC for acute
cholecystitis and showed mixed results in terms of mortal-
ity, morbidity, and postoperative recovery. [18,19] How-
ever, little is known about how different strategies for the
treatment of acute cholecystitis affect various clinical and
patient outcome measures, as well as resource utilization.
Therefore, in the present report, we describe the treatment
strategies for acute cholecystitis among 9 teaching hospi-
tals in Japan, and investigate the impact of treatment strat-
egies on patient outcomes and hospital revenues.
Methods
Subjects and database
The protocol of the present study was approved by the
institutional ethics committee of Kyoto University Gradu-
ate School of Medicine. The study settings were 9 general
hospitals, each of which has more than 350 beds, pro-
vides tertiary care, and is certified for residency training.
All of the hospitals are members of the Voluntary Hospi-
tals of Japan Quality Indicator Project (VHJ-QIP), which is
an initiative for gathering performance data for adminis-
trative and quality improvement activities.[10,20,21]
These participating hospitals provide the project with
administrative data concerning all discharged patients.
The administrative database includes patients' demo-
graphic data, classification of disease, information about
surgeries and complex procedures, length of hospital stay
(LOS), and medical claims.
Using this database, we identified 922 consecutive
patients who underwent cholecystectomy at one of the
participating hospitals between April 2001 and June
2003, and conducted a chart review. First, hospitalizations
for cholecystectomy were identified using the appropriate
diagnostic codes of the International Classification of Dis-
eases, Ninth Revision, Clinical Modification (ICD-9CM)
(Open cholecystectomy, 51.21–51.22; Laparoscopic
cholecystectomy, 51.23–51.24). From these cases, we
selected 254 cases with acute cholecystitis. Acute cholecys-
titis was defined as "inflammation of the gallbladder"
identified by ultrasonography or CT scanning, accompa-
nied by acute attacks of abdominal pain, fever (BT
>37.5°C), or laboratory markers of inflammation (white
blood cell count = 10,000). [22,23] Cases without gall-
stones (N = 1), or those complicated with hepatolithiasis
(N = 2) were excluded from the study. We also excluded
patients who developed acute cholecystitis during hospi-
talization (N = 3), and those whose clinical or charge data
were not perfect (N = 20). Consequently, 228 cases of
acute cholecystitis were analyzed.
Two or three independent reviewers collected the follow-
ing data: complications of choledocholithiasis; comorbid-
ities at admission; execution of percutaneous gallbladder
drainage; surgical information including operative proce-
dure (either LC or OC) and operative complications; post-
operative clinical course; discharge status; and medical
charges. Emergent cases were defined as those compli-
cated by severe jaundice, or with severe local complica-
tions such as biliary peritonitis, abscess, empyema,
gangrenous or emphysematous cholecystitis. Major intra-
operative complications included subcutaneous emphy-
sema, major bleeding (more than 20% of blood loss or
bleeding that required transfusion), common bile duct
injury, and bowel injury. Major postoperative complica-
tions included major postoperative bleeding, bile leakage,
bowel obstructions, severe infections such as blood
stream infections and pneumonia, acute cholangitis,
acute pancreatitis, cardiovascular events, and acute renal
failure. The postoperative time to oral intake was calcu-
lated by subtracting the date of operation from the date
when oral intake was started. When treatment was admin-
istered in more than one admission, LOS and medical
charges were summed across admissions. Medical charges
for ambulatory care were not included in the analyses
because data were not available.BMC Health Services Research 2006, 6:40 http://www.biomedcentral.com/1472-6963/6/40
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Analysis
Our analysis had 2 primary objectives: (1) to describe hos-
pital variation in the propensity to perform LC; and (2) to
examine the relationship between patient outcomes or
medical resource utilization and the propensity to per-
form LC after adjusting for patient risks. For the first
objective, our unit of analysis was the individual hospital.
For each hospital, we first calculated the observed rate of
LC to total cholecystectomies. The use of LC was defined
that LC was planned and completed. To account for
potential confounding by differences in patient character-
istics across hospitals, we used a multivariate logistic
regression model to calculate the adjusted rates of per-
forming LC. [24] Variables considered in the model
included age, sex, history of upper abdominal surgery,
complication of choledocholithiasis, acute pancreatitis or
acute cholangitis, comorbidity score (assessed by the
Charlson score [25,26]), and acuity of admission (urgent
or emergent). Variables significantly associated with the
likelihood of undergoing LC in the univariate analysis
were included in the final multivariate model. Adjusted
rates of LCs to total cholecystectomies were calculated
based on observed to expected (O/E) ratios predicted for
each hospital by this model.
To assess the relationship between laparoscopy use and
patient outcome, the 9 hospitals were first ranked accord-
ing to their propensity to perform laparoscopic surgery.
For each hospital, we assessed 5 primary outcome meas-
ures: lengths of stay (total, preoperative and postopera-
tive), major intra-operative complications, major
postoperative complications, number of days from sur-
gery to oral intake, and medical charges. We used analysis
of variance and multivariate linear regression techniques
to calculate adjusted LOS, adjusted postoperative time to
oral intake, and adjusted medical charges for each hospi-
tal and compared the means across hospitals. We used χ2
tests to assess differences in major postoperative compli-
cations, and used multivariate logistic regression tech-
niques to assess differences in the adjusted rate of
complications. Independent variables considered in these
models and the methods used for selecting variables for
the final model are described previously in this section.
Results
Variation in patients' backgrounds and the use of LC
In all hospitals, a significant difference was observed in
the distributions of age and comorbidity scores of the
patients with acute cholecystitis (Table 1 [See Additional
file 1]). The proportion of emergent cases did not differ
significantly among the hospitals. Either emergent opera-
tion or gallbladder drainage was performed in these cases.
Only one postoperative death was observed among all
subjects, resulting in an overall mortality of 0.3%. Previ-
ous studies have defined early operations as those per-
formed within 24 hours to 7 days or those performed on
the next operating list; [27] however, no case met the cri-
teria of early surgery except those that underwent emer-
gency operation. The 25th and 50th percentiles for
number of days between the onset of symptoms and
cholecystectomy were 14 days and 19 days, respectively.
Laparoscopic surgery was planned for 136 (59.7%)
patients, and performed on 104 (45.6%) patients, with an
overall conversion rate of 23.5%. No hospital in our study
performed mini-cholecystecomy. A large variation was
observed in the institutional use of LC for patients with
acute cholecystitis; the observed rates of LC to total chole-
cystectomies ranged from 21% to 95%. In multiple logis-
tic regression analysis, the factors significantly associated
with the performance of LC included age, history of upper
abdominal surgery, and acuity, while sex, comorbidity
score, and complication of choledocholithiasis, acute
pancreatitis, or acute cholangitis were not significant fac-
tors (Table 2 [See Additional file 1]). After adjusting for
these factors, LC propensity was still very different among
the hospitals; the adjusted rates ranged from 9.5% to 77%
(Table 1 [See Additional file 1]). The use of gallbladder
drainage also differed significantly among the hospitals;
the observed rates of gallbladder drainage ranged from
0% to 54% by hospital.
Relationships between laparoscopic use and clinical 
outcomes in patient-level analysis
In patient-level multiple linear regression analysis, the use
of LC was significantly associated with 2.4 days shorter
time to oral intake (P < 0.001), 7.3 days shorter total LOS
(P = 0.001), and 9.3 days shorter postoperative LOS (P <
0.001) after adjusting for patient risk factors such as age,
sex, comorbidity, history of upper abdominal surgery,
complication of choledocholithiasis, acute pancreatitis,
and acute cholangitis, and acuity. In our study, the overall
rate of intraoperative complication was significantly
higher in patients who requested LC when compared to
those whom requested OC (9.7% vs. 0%, P = 0.001). In
contrast, the incidence of postoperative complication did
not differ when patient age and comorbidity scores were
adjusted (P = 0.67).
Gallbladder drainage was more likely to be performed for
elderly patients (OR = 1.03; 95%CI, 1.01–1.07, P = 0.05),
and was significantly associated with fewer LC (OR = 0.49;
95%CI, 0.26–0.93; P = 0.03), longer preoperative LOS
(coefficient, 15.3; 95%CI, 10.7–19.9; P < 0.001), and
longer total LOS (coefficient, 13.3; 95%CI, 5.8–20.8; P <
0.001). Surgical fees did not differ widely between LC and
OC (US$ 3,713 ± 1,244 for LC and US$ 3,338 ± 1,185 for
OC). No significant difference in medical charges was
observed between LC and OC after adjustment for patient
risks (P = 0.85).BMC Health Services Research 2006, 6:40 http://www.biomedcentral.com/1472-6963/6/40
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Relationships between laparoscopic rates and patient 
outcomes in hospital-level analysis
Figure 1 [See Figure file] shows the adjusted means for
preoperative and postoperative LOS by hospital. In sum-
mary, we found no substantial association between hospi-
tals' use of LC and indicators of patient outcome, such as
LOS, medical charges, and adjusted rates of postoperative
complication. For example, the hospital with the highest
use of LC had the shortest average adjusted LOS (both pre-
operative and total), and the lowest adjusted rate of post-
operative complication; however, the hospital with the
second highest use had the longest LOS (both postopera-
tive and total).
We then divided the hospitals into three groups according
to the O/E ratio of performing LC; the first group included
86 patients of 4 hospitals whose O/E ratios were less than
1.0 (ranging from 0.21–0.83); the second group included
61 patients of 2 hospitals whose O/E ratios were around
1.0 (ranging from 1.02–1.03); and the last group included
81 patients of 3 hospitals whose O/E ratios were above 1.0
(ranging from 1.12–1.69). Table 3 [See Additional file 1]
shows the relationship between the propensity of per-
forming LC and patients' characteristics and outcomes.
A significant difference in the distribution of age and
comorbidity scores was observed among the three groups.
The intra-operative complication rate differed signifi-
cantly among the groups; the complication rate was low-
est among the hospital group with intermediate use of LC,
while it was highest in the group with the lowest use of
LC. In contrast, the incidence of postoperative comorbid-
ity did not differ. The adjusted mean number of days from
surgery to oral intake was significantly different among
the three groups; the group with the highest use of LC had
about one day shorter time to oral intake compared to the
other groups. After adjusting for patients' risk factors, we
found a significant difference in preoperative and postop-
erative LOS among the groups. Preoperative LOS was sig-
nificantly shorter in the hospital group with the lowest use
of LC, while postoperative LOS was significantly short in
the group with the highest use of LC. Consequently, there
was no difference in overall LOS among the groups. Prev-
alence of gallbladder drainage did not differ between the
Adjusted rate of LC to total cholecystectomies and adjusted LOS by hospital Figure 1
Adjusted rate of LC to total cholecystectomies and adjusted LOS by hospital. Hospitals are sorted by adjusted rate of LC. The 
blue column represents preoperative LOS, while the yellow column represents postoperative LOS.
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groups. However, prevalence of preoperative endoscopic
retrograde cholangio-pancreatography (ERCP) differed
according to LC propensity; higher use of LC was signifi-
cantly associated with a higher prevalence of preoperative
ERCP. Medical charges were not associated with the pro-
pensity for LC.
Discussion
Comparison of patient outcomes between LC and OC is
sometimes difficult because patients' characteristics and
risks often differ significantly between the two popula-
tions. Currently available evidence has shown mixed
results regarding the advantage of LC over OC for patients
with acute cholecystitis; thus, interpretation of these
results remains controversial. Although the randomized
controlled trial conducted by Kiviluoto et al. reported that
LC for acute and gangrenous cholecystitis reduces the
morbidity rate and sick leave, without increasing the mor-
tality rate, the surgeons who performed LC in this trial
were obviously more experienced with the procedure than
those who performed OC, which may reduce the validity
of this trial. [19] In another randomized trial conducted
by Johnson et al., these two approaches were equivalent in
terms of low morbidity and rapid postoperative recovery.
[18] A study from the United States, which investigated
small area variation in the use of LC among elderly
patients with AC, has shown that regions with relatively
high rates of LC for acute cholecystitis have shorter overall
hospital stays (approximately 1 day shorter). [12]
The present study demonstrated a large variation in the
treatment strategy for AC, as well as in the LC skills among
the hospitals. In addition, these hospitals showed rela-
tively homogeneous performance measures in terms of
LOS, and medical charges. Regardless of such a large vari-
ation in laparoscopy use, the incidence of major postop-
erative complications was not associated with LC
propensity after adjusting for patients' risk factors. On the
other hand, the incidence of intra-operative complica-
tions was higher in hospitals with the lowest use of LC.
Considering that intra-operative complications occurred
only among patients for whom LC was initially
attempted, this finding suggests that these complications
are more likely to occur during laparoscopic surgery by
surgeons with a relatively low LC volume. At the same
time, it was suggested that surgeons provide the proce-
dures they think commensurate with their skills and expe-
riences, and such decision-making is appropriate.
The studied hospitals had remarkably long overall hospi-
tal stay; the average overall LOS among our study subjects
was 30.9 days (range: 21.0 to 38.9 days), while the figures
in the reports from other countries range from only 5 to
10 days. [9,12,28] No hospital in our study adopted a pol-
icy of early surgery for the treatment of acute cholecystitis
during the study period. Reflecting this policy, the studied
hospitals had a remarkably long overall preoperative hos-
pital stay; the mean preoperative LOS was 17.1 days, and
the institutional means ranged from 8.0 to 21.3 days;
however, if the policy of early surgery were to be univer-
sally applied, we consider that the overall LOS would be
reduced by more than 10 days. Unfortunately, in Japan,
early surgery could impose a heavy burden on hospitals
that suffer from a lack of human resources.
In our data, the impact of LC use on the reduction of LOS
was small. Although postoperative LOS was significantly
shorter in hospitals with a high use of LC when compared
to those with low and intermediate use of LC, longer pre-
operative LOS in this group negated the advantage of LC
for reducing postoperative hospitalization. There are
some controversies regarding the impact of laparoscopic
surgery on the reduction of morbidity and hospital stays.
For example, several studies have suggested that mini-
cholecystectomy is a safe, inexpensive day surgery method
requiring minimal time off work after surgery, which is
comparable to LC, and questioned the application of this
technique for all cases. [29,30] However, these studies did
not limit subjects to patients with acute cholecystitis, and
therefore, the results may not be generalizable to the dis-
cussion regarding the treatment of acute cholecystitis.
Kehlet et al. reviewed articles investigating "fast-track sur-
gery", which include modifying perioperative care, such as
pain control, the introduction ofinnovative techniques
that reduce the perioperative stress response, and more
frequently use of minimal invasive surgical access. [31]
They critically reviewed randomized trials comparing
"open" and "laparoscopic" procedures, and indicated that
traditional care regimens have been infrequently revised
in the open treatment group. Therefore, they argue that
the studies in which LOS and convalescence were utilized
as endpoints may merely reflect traditions of periopera-
tive care associated with open procedures rather than dif-
ferences between open and closed surgical techniques.
The present study also revealed that the timing of surgery
and discharge are primarily determined by institutional
policy, rather than by the clinical course of the patient. For
example, the timing of surgery was not related to either
the use of LC or the use of gallbladder drainage. Moreover,
the hospitals' postoperative complication rates were not
associated with the mean postoperative LOS of the hospi-
tal, although they were significantly associated with the
mean postoperative time to oral intake. Such findings sug-
gest that the timing of discharge is determined by quite
different criteria among the providers, and that the length
of hospitalization is not necessarily an indicator of clini-
cal performance in Japan.BMC Health Services Research 2006, 6:40 http://www.biomedcentral.com/1472-6963/6/40
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The prevailing policy of delayed cholecystectomy with an
accompanying long hospitalization for patients with
acute cholecystitis may be attributable to the unique med-
ical system of Japan. In Japan, hospitals provide not only
acute care but also intermediate care and long-term care.
[32] Traditionally, surgical patients in Japan have stayed
in the hospital until they have completed convalescence,
at which time they can resume their normal life. Although
this tradition is now changing due to pressure from the
government and a shift in the medical payment system,
many healthcare providers continue to follow their tradi-
tional care regimen. Moreover, longer hospital stays do
not necessarily bring economic disadvantages to hospi-
tals. Since medical cost are usually reimbursed to hospi-
tals on a fee-for-service basis, a longer hospital stay yields
economic incentives for the hospital. Therefore, the utili-
zation of new technologies does not necessarily bring eco-
nomic benefits. For example, laparoscopic procedures are
often more time-consuming than traditional procedures,
at least during the 'learning curve', and they are also usu-
ally more expensive compared to open procedures,
mainly due to higher operating room costs for laparo-
scopic surgeries. [33]
Conclusion
Although our analysis documents a wide variation in LC
rates, it does not by itself answer the question, "Which rate
is right?" The institutional postoperative complication
rates, means of overall LOS and medical charges in our
study suggest that these two techniques are comparable in
terms of medical resource utilization. Contrary to the
results from clinical trials, in the real world, where sur-
geons' skills and patients' characteristics are much more
diverse than in experimental settings, the advantages of
LC have no direct bearing on patient outcomes. At the
same time, however, there is no doubt that LC is still supe-
rior to OC in terms of less postoperative suffering and less
pain for the patient. [34-36] Considering that the inci-
dence of postoperative complication and medical
resource utilization is comparable between OC and LC,
LC may be a superior strategy for the treatment of acute
cholecystitis. Unfortunately, the current healthcare pay-
ment system in Japan is based on a fee-for-service model
and provides no economic incentive for healthcare organ-
izations to reduce the length of hospitalization or to
reduce unnecessary medication and laboratory testing.
Reform of the medical system, including the separation of
acute care from intermediate care and nursing care, as well
as economic support for efficient medical resource utiliza-
tion, is necessary for facilitating the standardization of
treatment for acute cholecystitis based on scientific evi-
dence.
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